UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for tough liver cancer
Disease control CompletedThis study tested a combination of two drugs (durvalumab and SNDX-6352) in 5 adults with a rare liver cancer that could not be surgically removed. The goal was to see if the treatment was safe and could shrink tumors after standard liver-directed therapy. The trial is complete, a…
Matched conditions: UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 26, 2026 04:25 UTC
-
New Three-Drug cocktail shows promise for tough biliary cancers
Disease control CompletedThis study tested whether adding a third chemotherapy drug (nab-paclitaxel) to the standard two-drug regimen (gemcitabine and cisplatin) helps people with advanced bile duct or gallbladder cancer live longer. The trial enrolled 452 patients with newly diagnosed, advanced disease …
Matched conditions: UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 22, 2026 14:04 UTC